The global antibody contract manufacturing market was valued at USD 18.17 Billion in 2024, driven by the rising incidence of chronic diseases across the globe. The market is anticipated to grow at a CAGR of 12.20% during the forecast period of 2025-2034, with the values likely to reach USD 57.45 Billion by 2034.
Base Year
Historical Year
Forecast Year
Antibody contract manufacturing involves the production of biologic therapies, including monoclonal antibodies (mAb), polyclonal antibodies, and others. These therapeutics target specific antigens to treat cancer, autoimmune disorders, and infectious diseases. With advancements in mAbs, bispecific antibodies, and antibody-drug conjugates (ADCs), the market is poised for substantial growth in the forecast period.
Rising Prevalence of Chronic Diseases is Likely to Drives Market Growth
According to the Centers for Disease Control and Prevention (CDC) 2024 report, approximately 129 million people in the United States (including children and adults) are affected by one or more major chronic illnesses including heart disease, cancer, diabetes, obesity, and hypertension illnesses. The rising prevalence of chronic diseases is driving market demand for antibody contract manufacturing as the need for effective therapeutic alternatives against chronic diseases is on the rise.
Several trends and developments are being observed in the market to enhance the current situation. Some of the noteworthy trends are as follows:
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Product
Market Breakup by Source
Market Breakup by Therapeutic Area
Market Breakup by End User
Market Breakup by Region
Market Segmentation Based on the Product is Anticipated to Witness Substantial Growth
Based on product, the market is divided into monoclonal antibodies, polyclonal antibodies, and others. Among these, the monoclonal antibody segment leads the market share due to its extensive applications in oncology, immunology, and therapies for autoimmune conditions. The market share for targeted therapies is expected to grow further as its adoption witnesses an increase and biotechnology advances.
Regionally, the market report offers an insight into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Among these, North America is expected to dominate the market because of the presence of major pharmaceutical companies and substantial healthcare expenditures. Intensive research efforts and government support for cancer research are fueling the expansion of the domestic market.
The key features of the market report include patent analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies are:
Founded in 1897, this company is headquartered in Basel, Switzerland, it is one of the largest companies providing a wide range of antibody contract manufacturing services, with a focus on monoclonal antibody production. Some of their products include Darzalex® (daratumumab), and Avastin (bevacizumab), among others. The company offers mammalian cell culture technologies, process development, and commercial manufacturing on an industrial scale.
Founded in 2006, Thermo Fisher Scientific is based in Waltham, Massachusetts, USA. The company offer...
Founded in 2010 and headquartered in Wuxi, China, they have produced antibodies like Imfinzi® (durv...
FUJIFILM Holdings is a leading company in the manufacture of antibody contract services, established...
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other companies include Samsung Biologics Co., Ltd., Charles River Laboratories, AGC Biologics, Cytovance Biologics, Inc., Emergent BioSolutions, Labcorp Drug Development, Catalent, Inc., and Boehringer Ingelheim Biopharmaceuticals GmbH.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2024 |
| Historical Period | 2018-2024 |
| Forecast Period | 2025-2034 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by Source |
|
| Breakup by Therapeutic Area |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share